Cite
APA Citation
Abboretti, F., Lambert, C., Schäfer, M., Le Roy, B., Mège, D., Demartines, N., Pezet, D., Gronnier, C., & Mantziari, S. (n.d.). 43: NEOADJUVANT CHEMOTHERAPY OFFERS NO SURVIVAL BENEFIT FOR CT2N0M0 GASTRIC ADENOCARCINOMA. A MULTICENTRIC EUROPEAN STUDY. Diseases of the esophagus, 35, . http://access.bl.uk/ark:/81055/vdc_100153790979.0x000022